CPRI enters the final week of August with a sharp and sudden re-build of bearish positioning, even as the stock has already lost more than a third of its value since the start of the year.
The standout this week is the single-session surge in short interest. Bears added roughly 1.96 million shares on Tuesday alone — a 27% jump that pushed short interest to 7.8% of the free float, the highest reading in over a month and well above mid-August lows near 6.1%. That move reverses a steady unwind that ran from late July through mid-August, when shorts had trimmed from above 10% of float down to the mid-6s. The speed of the rebuild — nearly two million shares in one session — is the more striking detail. It suggests a deliberate new bet rather than a slow drift. That said, the lending market offers no squeeze tension to speak of: borrow costs run at just 0.64%, and availability is extraordinarily loose at nearly 1,393% of short interest, meaning there are roughly fourteen shares available to borrow for every one currently lent out. Fresh supply for new short positions is effectively unlimited at current levels.
Options positioning has turned more defensive alongside the short rebuild. The put/call ratio climbed to 0.55 — running almost two standard deviations above its 20-day average of 0.47 — the most skewed reading in several weeks. The stock itself has fallen 7.8% over the past week and 13.9% over the past month to close at $13.30. It is also down more than 40% year-to-date, a pace of decline that compares poorly even against a weak week for apparel peers: fell 4.1% and dropped 4.1% on the week, while slipped 0.9% — all negative, but none close to CPRI's trajectory.
The Street's assessment has not improved materially since the Q1 report. Analysts cut targets en masse in early August: Goldman Sachs trimmed to $18, TD Cowen downgraded to Hold with a $17 target, and JPMorgan lowered its target from $29 to $22 while keeping Overweight. The consensus now sits at Hold across 13 analysts (five Buy, eight Hold), with a mean price target of $22.66 — implying roughly 70% upside from the current print. That gap is large, but it reflects where analysts wrote their models, not fresh conviction; the most recent target cuts came three weeks ago and the stock has continued to slide since. The bull case rests on Michael Kors profitability recovery and potential corporate actions; the bear case is more immediate — a projected 9% revenue decline in Q2 2027, a 5% operating margin, and little near-term catalyst. At a PE of 6.5x and EV/EBITDA of 9.4x, the multiple is undemanding, but compressing earnings make those ratios a moving target. The ORTEX short score ticked up sharply to 45.5 from 41.4 the prior session, the highest reading in recent weeks, tracking the directional shift in positioning.
Institutional holders have generally been adding rather than trimming. BlackRock lifted its stake to 13% of shares (up 544,000 shares at the last report), Arrowstreet built a substantial new position of over 2 million shares, and Norges Bank added nearly 1.5 million shares through June. Those moves predate the August slide, so whether they represent conviction or positions still being digested is unclear. Insider activity through late July was confined to routine director award-and-sell pairs — multiple board members received and immediately sold a portion of their annual equity grants at $15.83 — carrying no real signal for direction.
The next earnings event is scheduled for November 6. After the August 5 print, the stock fell 9.2% in a single session and lost a further 5.9% over five days. With short interest now rebuilding at pace, borrow remaining cheap, and the options market growing more defensive, the key question into autumn is whether the Michael Kors brand trajectory shows any stabilisation — or whether Tuesday's short spike marks the beginning of a new leg lower.
See the live data behind this article on ORTEX.
Open CPRI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
